Myopathy and rhabdomyolysis with lipid-lowering drugs
- 20 January 2002
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 128 (1-3) , 159-168
- https://doi.org/10.1016/s0378-4274(02)00010-3
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil.American Journal of Health-System Pharmacy, 2000
- Malignant hyperthermiaThe Lancet, 1998
- An investigation into the role of rat skeletal muscle as a site for xenobiotic metabolism using microsomes and isolated cellsHuman & Experimental Toxicology, 1997
- SimvastatinThe Lancet, 1992
- Enantiomers of clofibric acid analogs have opposite actions on rat skeletal muscle chloride channelsPflügers Archiv - European Journal of Physiology, 1988
- Comparative toxicity and safety profile of fenofibrate and other fibric acid derivativesThe American Journal of Medicine, 1987
- Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogsJournal of Medicinal Chemistry, 1987
- Clofibrate-Induced Myotoxicity in RatsEuropean Neurology, 1983
- CLOFIBRATE, NEPHROTIC SYNDROME, AND HISTOLOGICAL CHANGES IN MUSCLEThe Lancet, 1973
- COMPLICATIONS DURING CLOFIBRATE TREATMENT OF NEPHROTIC-SYNDROME HYPERLIPOPROTEINÆMIAThe Lancet, 1972